Sfoglia per AUTORE
ALDEA M
Collezione ASL Cuneo 2
Items : 3
1294P Non-adenocarcinoma histology in patients with RET+ lung cancer: Response to RET-inhibitors and survival from the RET-MAP registry in Annals of Oncology
2024
ASL Cuneo 2
ASL Cuneo 2
Marinello A; Massa G; Rotow J; Bote De Cabo H; Monnet I; Guisier F; Duruisseaux M; Benitez Montanez JC; Raimbourg J; Costa J; Tagliamento M; Feng J; Di Federico A; Metro G; Citarella F; Tabbò F; Lindsay C; Iranzo Gomez P; Besse B; Aldea M;
1343P Adding histology-driven chemotherapy (ChT) to overcome primary resistance to first-line immunotherapy (ICI) in patients (pts) with advanced non-small cell lung cancer (aNSCLC) with PD-L1 ?50% in Annals of Oncology
2024
ASL Cuneo 2
ASL Cuneo 2
De Giglio A; Zullo L; Di Federico A; Cani M; Aldea M; Favorito V; Sadowska A; Hendriks LE; Gorría Puga T; Mezquita L; Tabbò F; Novello S; Ardizzoni A; Besse B; Gelsomino F;
1343P Adding histology-driven chemotherapy (ChT) to overcome primary resistance to first-line immunotherapy (ICI) in patients (pts) with advanced non-small cell lung cancer (aNSCLC) with PD-L1 ?50% in Annals of Oncology
2024
ASL Cuneo 2
ASL Cuneo 2
De Giglio A; Zullo L; Di Federico A; Cani M; Aldea M; Favorito V; Sadowska A; Hendriks LE; Gorría Puga T; Mezquita L; Tabbò F; Novello S; Ardizzoni A; Besse B; Gelsomino F;